---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-23-005387"
form_type: "8-K"
ticker: "PMDI"
cik: "0000806517"
company_name: "PSYCHEMEDICS CORP"
filed_at: "2023-08-21T23:59:59+00:00"
generated_at: "2026-06-11T06:39:23.480565+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Psychemedics grants 300,000 inducement options to new CEO; Nevin elected Chairman

## Summary
- Inducement options to purchase 300,000 shares granted to CEO Brian Hullinger at $4.65/share exercise price.
- Options vest in three tranches: 100,000 time-based over 2 years; 200,000 performance-based on stock price targets.
- Darius G. Nevin elected Chairman of the Board, succeeding Raymond C. Kubacki who retired on August 17, 2023.
- Annual meeting results: All six director nominees elected; advisory vote on exec compensation approved; BDO USA ratified as auditor.

## SEC filing metadata
- accession: 0001171843-23-005387
- form_type: 8-K
- ticker: PMDI
- cik: 0000806517
- company_name: PSYCHEMEDICS CORP
- filed_at: 2023-08-21T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 5.07, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/806517/000117184323005387/0001171843-23-005387-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/806517/000117184323005387/f8k_082123.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-23-005387
- JSON: https://secwatch.observer/filing/0001171843-23-005387.json
- Plain text: https://secwatch.observer/filing/0001171843-23-005387.txt

## Key facts
- Shareholder Votes
  PSYCHEMEDICS CORP shareholders approved Election of six directors to serve until the 2024 Annual Meeting.
  - Proposal: director election
  - Outcome: passed
  source text: Proposal No. 1. Election of Directors. The stockholders elected six directors to serve until the Company's 2024 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified, by the votes set forth in the table below: Nominees For Withheld Broker Non-Votes Robyn C. Davis 2,898,919 140,670 1,228,741 Brian Hullinger 2,996,505 43,084 1,228,741 Peter H. Kamin 2,974,032 65,557 1,228,741 Darius G. Nevin 2,938,911 100,678 1,228,741 Andrew M. Reynolds 2,805,910 233,679 1,228,741
  evidence_url: https://www.sec.gov/Archives/edgar/data/806517/000117184323005387/0001171843-23-005387-index.htm
- Shareholder Votes
  PSYCHEMEDICS CORP shareholders approved Advisory vote on executive compensation.
  - Proposal: say on pay
  - Outcome: passed
  source text: Proposal No. 2. Advisory Vote on Executive Compensation. The stockholders approved a non-binding advisory resolution to approve executive compensation, as described in the Proxy Statement, by the votes set forth in the table below: For Against Abstain Broker Non-Votes 2,855,077 170,531 13,981 1,228,741
  evidence_url: https://www.sec.gov/Archives/edgar/data/806517/000117184323005387/0001171843-23-005387-index.htm
- Shareholder Votes
  PSYCHEMEDICS CORP shareholders approved Ratification of appointment of BDO USA, P.A. as independent registered public accounting firm at the 2023-12-31 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2023-12-31
  source text: Proposal No. 3. Ratification of Appointment of Independent Registered Public Accounting Firm. The stockholders ratified the appointment of BDO USA, P.A. as the Company's independent registered public accounting firm for the year ending December 31, 2023, by the votes set forth in the table below: For Against Abstain Broker Non-Votes 4,223,842 36,638 7,850 0
  evidence_url: https://www.sec.gov/Archives/edgar/data/806517/000117184323005387/0001171843-23-005387-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.